for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Clovis Oncology To Highlight Rubraca And Lucitanib Non-Clinical Data At The AACR Virtual Annual Meeting II 2020

June 17 (Reuters) - Clovis Oncology Inc:

* CLOVIS ONCOLOGY TO HIGHLIGHT RUBRACA® (RUCAPARIB) AND LUCITANIB NON-CLINICAL DATA AT THE AACR VIRTUAL ANNUAL MEETING II 2020 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up